CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
letrozole in advanced stage, persistent or recurrent endometrioid endometrial cancer at 6 months. Treatment will continue until eit...
Phase 2
Salt Lake City, Utah, United States and 28 other locations
to evaluate the efficacy and safety of ACR-368 as monotherapy or with ultra-low dose gemcitabine (ULDG) sensitization in participants with endometrial...
Phase 2
Salt Lake City, Utah, United States and 69 other locations
This study will test the safety, including side effects, and determine the characteristics of a drug called Rina-S in participants with solid tumors...
Phase 1, Phase 2
West Valley City, Utah, United States of America and 55 other locations
The purpose of this study is to characterize the safety, tolerability, and efficacy of IDE161 as a single agent and in combination with pembrolizumab.
Phase 1
West Valley City, Utah, United States of America and 26 other locations
The goal of the Dose Escalation phase of the study is to evaluate the safety, tolerability, pharmacokinetics (PK) and preliminary anti-tumor...
Phase 1
Salt Lake City, Utah, United States and 18 other locations
The purpose of this study is to find out whether the study drug, LY4170156, is safe, tolerable and effective in participants with advanced solid tumors...
Phase 1
West Valley City, Utah, United States of America and 23 other locations
and tolerability, and to determine the maximum tolerated dose and / or recommended phase 2 dose of LNCB74 in participants with advanced solid tumors...
Phase 1
Salt Lake City, Utah, United States and 13 other locations
-small-cell lung cancer (NSCLC), triple negative breast cancer (TNBC), ovarian cancer (OC), endometrial cancer...
Phase 1
Salt Lake City, Utah, United States and 123 other locations
This is a Phase 1/2, open-label, multicenter study evaluating the safety, tolerability, pharmacokinetics, pharmacodynamics and anti-tumor ac...
Phase 1, Phase 2
West Valley City, Utah, United States and 9 other locations
A Study of XMT-1660 in Solid Tumors...
Phase 1
Salt Lake City, Utah, United States and 25 other locations
Clinical trials
Research sites
Resources
Legal